Faron Pharmaceuticals - Innovative medical solutions (Part 2)

A recent, not yet peer-reviewed study from Helsinki on pediatric cancers (neuroblastoma).
Among other things, Clever-1 was detected in them.

Neuroblastoma immune microenvironment is characterized by limited T cell infiltration and abundant macrophages expressing targetable receptors

https://www.biorxiv.org/content/10.64898/2026.11.09.764906v1.full.pdf

8 Likes